# Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

> **NCT00290628** · NA · TERMINATED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 43 (actual)

## Conditions studied

- Chronic Myeloproliferative Disorders
- Diamond-blackfan Anemia
- Fanconi Anemia
- Graft Versus Host Disease
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Diseases

## Interventions

- **DRUG:** anti-thymocyte globulin
- **DRUG:** busulfan
- **DRUG:** cyclophosphamide
- **DRUG:** cyclosporine
- **DRUG:** filgrastim
- **DRUG:** melphalan
- **DRUG:** methylprednisolone
- **DRUG:** mycophenolate mofetil
- **PROCEDURE:** radiation therapy
- **PROCEDURE:** umbilical cord blood transplantation

## Key facts

- **NCT ID:** NCT00290628
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1999-10
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 43 (ACTUAL)
- **Why stopped:** Replaced with another study
- **Last updated:** 2017-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00290628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00290628, "Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00290628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*